Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase. Canadian Dermatology Today, Toronto, Canada, v. 7, n. 3, p. 4–10, 2026. DOI: 10.58931/cdt.2026.73167. Disponível em: https://canadiandermatologytoday.com/article/view/7-3-Netchiporouk_et_al. Acesso em: 28 sep. 2026.